Clinical Research Directory
Browse clinical research sites, groups, and studies.
Efficacy and Safety of KAI-9531 Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes
Sponsor: Kailera
Summary
The primary objective of this study is to demonstrate that KAI-9531 subcutaneous (SC) injection once weekly is superior to semaglutide SC once weekly and to placebo SC once weekly on percent change in body weight.
Official title: A Phase 3, Randomized, Active- and Placebo-Controlled, Partially-Blinded Study to Compare the Efficacy and Safety of KAI-9531 Administered Once Weekly Versus Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
1200
Start Date
2025-12-30
Completion Date
2028-04-17
Last Updated
2026-03-13
Healthy Volunteers
No
Conditions
Interventions
KAI-9531
SC Injection
Semaglutide
SC Injection
Placebo
SC Injection
Locations (25)
Kailera Clinical Site
Glendale, Arizona, United States
Kailera Clinical Site
Phoenix, Arizona, United States
Kailera Clinical Site
Little Rock, Arkansas, United States
Kailera Clinical Site
Northridge, California, United States
Kailera Clinical Site
Oceanside, California, United States
Kailera Clinical Site
Hamden, Connecticut, United States
Kailera Clinical Site
Stamford, Connecticut, United States
Kailera Clinical Site
Orange City, Florida, United States
Kailera Clinical Site
Albany, Georgia, United States
Kailera Clinical Site
Chicago, Illinois, United States
Kailera Clinical Site
Newton, Kansas, United States
Kailera Clinical Site
Shreveport, Louisiana, United States
Kailera Clinical Site
Farmington Hills, Michigan, United States
Kailera Clinical Site
Missoula, Montana, United States
Kailera Clinical Site
Las Vegas, Nevada, United States
Kailera Clinical Site
Albany, New York, United States
Kailera Clinical Site
Morehead City, North Carolina, United States
Kailera Clinical Site
Norman, Oklahoma, United States
Kailera Clinical Site
East Greenwich, Rhode Island, United States
Kailera Clinical Site
North Charleston, South Carolina, United States
Kailera Clinical Site
Spartanburg, South Carolina, United States
Kailera Clinical Site
Brownsville, Texas, United States
Kailera Clinical Site
San Antonio, Texas, United States
Kailera Clinical Site
Manassas, Virginia, United States
Kailera Clinical Site
Richmond, Virginia, United States